These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Salmon-coloured granules in residual acute myeloid leukaemia with t(8;21)(q22;q22.1); RUNX1-RUNX1T1. Chen D; Chen W Br J Haematol; 2021 May; 193(4):691. PubMed ID: 33386742 [No Abstract] [Full Text] [Related]
3. Myeloid neoplasms with t(16;21)(q24;q22)/RUNX1-RUNX1T3 mimics acute myeloid leukemia with RUNX1-RUNX1T1. Liu H; Wang SA; Schlette EJ; Xu J; Jorgensen JL; Cameron Yin C; Li S; Jeffrey Medeiros L; Tang G Ann Hematol; 2018 Oct; 97(10):1775-1783. PubMed ID: 29872884 [TBL] [Abstract][Full Text] [Related]
4. The First Case of Acute Myeloid Leukemia With a Novel Five-way Variant Translocation of Jo YH; Han EA; Park SK; Jeon BR; Jang MA Ann Lab Med; 2023 May; 43(3):315-318. PubMed ID: 36544347 [No Abstract] [Full Text] [Related]
5. Olaparib combined with low-dose chemotherapy for relapsed Lin L; Xue S; Chen J; Gu C; Zhang J; Xing E; Wang W; Wang L; Zhang Z Leuk Lymphoma; 2024 Aug; 65(8):1181-1185. PubMed ID: 39041737 [No Abstract] [Full Text] [Related]
6. Novel Four-Way t(8;14;15;21)(q22;q22;q15;q22.1) Translocation Variant in Acute Myeloid Leukemia with Tsuge N; Ogasawara F; Kondo T; Yoshida S; Kojima K Turk J Haematol; 2024 May; 41(2):128-129. PubMed ID: 38488305 [No Abstract] [Full Text] [Related]
7. The dynamics of RUNX1-RUNX1T1 transcript levels after allogeneic hematopoietic stem cell transplantation predict relapse in patients with t(8;21) acute myeloid leukemia. Qin YZ; Wang Y; Xu LP; Zhang XH; Chen H; Han W; Chen YH; Wang FR; Wang JZ; Chen Y; Mo XD; Zhao XS; Chang YJ; Liu KY; Huang XJ J Hematol Oncol; 2017 Feb; 10(1):44. PubMed ID: 28166825 [TBL] [Abstract][Full Text] [Related]
8. The RUNX1/RUNX1T1 network: translating insights into therapeutic options. Swart LE; Heidenreich O Exp Hematol; 2021 Feb; 94():1-10. PubMed ID: 33217477 [TBL] [Abstract][Full Text] [Related]
9. Prognostic Role of Postinduction Minimal Residual Disease and Myeloid Sarcoma Type Extramedullary Involvement in Pediatric RUNX1-RUNX1T1 (+) Acute Myeloid Leukemia. Lee JW; Kim S; Jang PS; Chung NG; Cho B; Im SA; Kim M J Pediatr Hematol Oncol; 2020 Apr; 42(3):e132-e139. PubMed ID: 31688618 [TBL] [Abstract][Full Text] [Related]
10. [The study of clinical characteristics and prognosis of RUNX1-RUNX1T1 positive acute myeloid leukemia based on next-generation sequencing]. Wang YL; Gao SJ; Su L; Liu YJ; Zhang YW; Du YZ Zhonghua Xue Ye Xue Za Zhi; 2023 Oct; 44(10):851-854. PubMed ID: 38049338 [No Abstract] [Full Text] [Related]
11. Allogeneic hematopoietic stem cell transplantation can improve the prognosis of high-risk pediatric t(8;21) acute myeloid leukemia in first remission based on MRD-guided treatment. Hu GH; Cheng YF; Lu AD; Wang Y; Zuo YX; Yan CH; Wu J; Sun YQ; Suo P; Chen YH; Chen H; Jia YP; Liu KY; Han W; Xu LP; Zhang LP; Huang XJ BMC Cancer; 2020 Jun; 20(1):553. PubMed ID: 32539815 [TBL] [Abstract][Full Text] [Related]
12. Simultaneous occurrence of two distinct leukemic clones with PML-RARα and RUNX1-RUNX1T1 in a case of acute myeloid leukemia. Shao H; Yang Q; Zhang P; Liu H; Wu C; Cen J; Qiu H; Chen S; Pan J Ann Hematol; 2018 Mar; 97(3):529-531. PubMed ID: 29124313 [No Abstract] [Full Text] [Related]
13. Not only mutations but also tumorigenesis can be substantially attributed to DNA damage from reactive oxygen species in RUNX1::RUNX1T1-fusion-positive acute myeloid leukemia. Mandell JD; Fisk JN; Cyrenne E; Xu ML; Cannataro VL; Townsend JP Leukemia; 2022 Dec; 36(12):2931-2933. PubMed ID: 36369483 [No Abstract] [Full Text] [Related]
14. Minimal residual disease (MRD) monitoring and mutational landscape in AML with RUNX1-RUNX1T1: a study on 134 patients. Höllein A; Jeromin S; Meggendorfer M; Fasan A; Nadarajah N; Kern W; Haferlach C; Haferlach T Leukemia; 2018 Oct; 32(10):2270-2274. PubMed ID: 29568097 [No Abstract] [Full Text] [Related]
15. Optimized clinical application of minimal residual disease in acute myeloid leukemia with RUNX1-RUNX1T1. Wei H; Liu X; Wang Y; Lin D; Zhou C; Liu B; Qiu S; Gu R; Li Y; Wei S; Gong B; Liu K; Gong X; Liu Y; Zhang G; Fang Q; Zhang J; Jin J; Ma Y; Mi Y; Wang J Exp Hematol; 2021 Apr; 96():63-72.e3. PubMed ID: 33524443 [TBL] [Abstract][Full Text] [Related]
16. Rare Pseudo-Chediak-Higashi Inclusions in Therapy-Related Acute Myeloid Leukemia with Myelodysplasia-Related Changes. Fan Y; Jiang L; Wang N; Liu X; Zhang L Clin Lab; 2023 May; 69(5):. PubMed ID: 37145084 [TBL] [Abstract][Full Text] [Related]
17. Elucidation of Novel Therapeutic Targets for Acute Myeloid Leukemias with Yun JW; Bae YK; Cho SY; Koo H; Kim HJ; Nam DH; Kim SH; Chun S; Joo KM; Park WY Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30959925 [TBL] [Abstract][Full Text] [Related]
18. FACSorting help to analyze a rare case of acute myeloid leukemia with concurrent AML1-ETO and PML-RARA. Chen M; Fu M; Wang A; Wu X; Zhen J; Gong M; Wu P; Du Q; Wang T; Liu H; Wang H Int J Lab Hematol; 2021 Dec; 43(6):e276-e279. PubMed ID: 33943002 [No Abstract] [Full Text] [Related]
19. Co-expression of AML1-ETO and PML-RARa following treatment of de novo acute myeloid leukemia with AML1-ETO. Zhang S; Zhou W; Li Y; Yu S; Xue M; Qiao Y; Jian J; Liu B; Wang D Leuk Lymphoma; 2019 May; 60(5):1316-1319. PubMed ID: 30328750 [No Abstract] [Full Text] [Related]
20. High number of additional genetic lesions in acute myeloid leukemia with t(8;21)/RUNX1-RUNX1T1: frequency and impact on clinical outcome. Krauth MT; Eder C; Alpermann T; Bacher U; Nadarajah N; Kern W; Haferlach C; Haferlach T; Schnittger S Leukemia; 2014 Jul; 28(7):1449-58. PubMed ID: 24402164 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]